11-45847531-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000616080.2(CRY2):c.41C>A(p.Ala14Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000768 in 1,431,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A14V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000616080.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRY2 | NM_021117.5 | c.41C>A | p.Ala14Glu | missense_variant | 1/12 | ENST00000616080.2 | NP_066940.3 | |
CRY2 | NM_001127457.3 | c.32+250C>A | intron_variant | NP_001120929.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRY2 | ENST00000616080.2 | c.41C>A | p.Ala14Glu | missense_variant | 1/12 | 1 | NM_021117.5 | ENSP00000484684 | P2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000535 AC: 10AN: 187018Hom.: 0 AF XY: 0.0000386 AC XY: 4AN XY: 103524
GnomAD4 exome AF: 0.00000768 AC: 11AN: 1431606Hom.: 0 Cov.: 36 AF XY: 0.00000704 AC XY: 5AN XY: 710336
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.104C>A (p.A35E) alteration is located in exon 1 (coding exon 1) of the CRY2 gene. This alteration results from a C to A substitution at nucleotide position 104, causing the alanine (A) at amino acid position 35 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at